Colorectal cancer liver metastasis
Conditions
Interventions
Group of Neoadjuvant Chemotherapy:None
Group of Neoadjuvant Chemotherapy combined with Bevacizumab:None
Sponsors
Fujian Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) The primary tumor was histologically confirmed as colorectal adenocarcinoma, which was resectable or resected; (2) aged 18 years or above; (3) The liver mass was confirmed as colorectal cancer metastasis by conventional pathology; (4) Liver metastases were evaluated as resectable status before neoadjuvant chemotherapy; (5) Patients had not received any local treatment before neoadjuvant therapy, including radiotherapy, interventional therapy, etc. (6) Patients with CRS score > 2 points and good function of important organs.
Exclusion criteria
Exclusion criteria: (1) subjects who used anticoagulants, hormones, immunosuppressants, or drugs of abuse before surgery (which may interfere with the test results); (2) patients with a history of malignant tumors other than colorectal cancer; (3) Distant metastasis outside the liver was found by preoperative imaging or during operation; (4) missing important clinical data, including lost follow-up; (5) any diseases that may interfere with the test results after evaluation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| patient information; | — |
Countries
China
Contacts
Public ContactLi Weihua
Fujian Provincial Hospital
Outcome results
None listed